Health ❯ Healthcare

Obesity

Treatment Options Weight Management Weight Loss Weight Loss Treatments Treatment Weight Loss Drugs Obesity Treatment Medications Health Risks Obesity Management

Experimental Endoscopic Procedure Shows Promise in Slowing Weight Regain After GLP-1 Drugs

Most patients regain much of the weight after stopping GLP-1 drugs, prompting trials of tools to keep the loss.

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

Trial Hints ‘Gut Reset’ May Slow Weight Regain After Stopping GLP‑1 Drugs

Amazon Rolls Out Nationwide GLP-1 Care Program Through One Medical

Kailera Leaps 62% in Nasdaq Debut After $625 Million IPO

GLP-1 Pills Accelerate into U.S. Care with Amazon Rollout and New Evidence on Use and Response

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

DNA Links Found for Who Loses Weight and Who Gets Sick on GLP-1 Drugs

Amazon Pharmacy Launches Same-Day Delivery for Lilly’s Foundayo Weight-Loss Pill

Mexico Renews Warning as Counterfeit GLP-1 Weight-Loss Drugs Spread Worldwide

FDA Clears Eli Lilly’s Foundayo Oral GLP-1 for Weight Loss, With U.S. Launch Set for April 6

FDA Clears Lilly’s Foundayo Pill, Escalating GLP-1 Weight-Loss Rivalry

GSK Gains After Cramer Endorsement as Company Pushes Into Weight-Loss Drugs

Gold-Standard Scans Show BMI Often Mislabels Overweight and Obesity, Study Finds

Studies Link GLP-1 Drugs to Lower Addiction and Overdose Risks

Stiftung Warentest Backs Only Mounjaro and Wegovy for Durable Weight Loss

India Tightens Oversight of GLP-1 Drugs as Semaglutide Generics Proliferate

Wave Life Sciences Shares Plunge 30% After Early Obesity Trial Readout

Report Says BMI Rules Shut Patients Out of NHS Hip and Knee Surgery

India Tightens Oversight as Low‑Cost Semaglutide Hits Pharmacies